NYSE$RMD
ResMed Inc · Q2 2025 earnings
Q2 2025 earnings · · After market close · Investor relations
Briefing
ResMed's Q2 2025 results announced with revenue increasing, operating profit surging, and non-GAAP operating profit also experiencing growth.
ResMed Inc. reported a 10% increase in revenue to $1.3 billion, a 52% increase in operating profit, and a 19% increase in non-GAAP operating profit for the second quarter of fiscal year 2025. The company's diluted earnings per share was $2.34, with a non-GAAP diluted earnings per share of $2.43. Operating cash flow was $309 million.
- Revenue increased by 10% to $1.3 billion; up 10% on a constant currency basis.
- Gross margin improved 300 bps to 58.6%; non-GAAP gross margin improved 230 bps to 59.2%.
- Income from operations increased 52%; non-GAAP income from operations up 19%.
- Diluted earnings per share of $2.34; non-GAAP diluted earnings per share of $2.43.
Headline financials
Revenue & EPS history
ResMed · Revenue · Quarterly
$1.28B
Revenue by segment
ResMed · $963M total across 2 segments · Q1 2024
- Total Devices$565M—58.6%
- Total Masks and other$398M—41.4%
Forward guidance
ResMed provided forward guidance, but the details were not specified in the provided text.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2025
+0.1%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.2%
Avg return
30 days after
49%
33 / 67 earnings
Positive
+18.7%
Q3 2024
Best reaction
-19.3%
Q2 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -2.9% | -2.0% | -10.8% | |
| Q2 2026 | -1.5% | +2.1% | -0.5% | |
| Q1 2026 | -1.5% | -2.8% | +1.4% | |
| Q3 2025 | +10.1% | +10.9% | +13.2% | |
| Q2 2025 | -8.3% | -5.8% | -9.4% | |
| Q1 2025 | +7.9% | +2.9% | +2.7% | |
| Q4 2024 | +4.9% | +2.6% | +14.9% | |
| Q3 2024 | +18.7% | +16.4% | +16.0% | |
| Q2 2024 | +6.5% | +9.3% | +5.2% | |
| Q1 2024 | -4.2% | +0.5% | +9.5% | |
| Q4 2023 | -19.3% | -19.3% | -28.3% | |
| Q3 2023 | +7.6% | +5.4% | -3.8% | |
| Q2 2023 | -2.8% | -1.2% | -8.5% | |
| Q1 2023 | -6.5% | -5.6% | -1.7% | |
| Q4 2022 | -1.5% | -3.1% | -3.1% | |
| Q3 2022 | -6.9% | -8.5% | -3.0% | |
| Q2 2022 | -6.5% | +0.5% | +6.2% | |
| Q1 2022 | -1.9% | -2.1% | -6.3% | |
| Q4 2021 | +0.5% | +0.7% | +8.3% | |
| Q3 2021 | -10.6% | -8.6% | -2.0% | |
| Q2 2021 | -5.8% | -3.5% | -9.9% | |
| Q1 2021 | +6.2% | +12.1% | +16.0% | |
| Q4 2020 | -13.4% | -13.6% | -14.4% | |
| Q3 2020 | +1.8% | +2.0% | +2.9% | |
| Q2 2020 | -4.1% | +0.6% | -4.1% | |
| Q1 2020 | +13.8% | +15.7% | +14.6% | |
| Q4 2019 | +1.1% | +3.8% | +5.4% | |
| Q3 2019 | +7.9% | +7.6% | +9.3% | |
| Q2 2019 | -19.3% | -21.5% | -13.6% | |
| Q1 2019 | +6.2% | +7.3% | +5.7% | |
| Q4 2018 | -2.1% | +0.7% | +4.1% | |
| Q3 2018 | -2.1% | -1.4% | +6.9% | |
| Q2 2018 | +13.2% | +15.9% | +5.1% | |
| Q1 2018 | +7.7% | +7.4% | +8.6% | |
| Q4 2017 | -6.0% | -2.6% | +0.6% | |
| Q3 2017 | -5.2% | -2.7% | -2.3% | |
| Q2 2017 | +9.5% | +7.1% | +13.7% | |
| Q1 2017 | -5.0% | -5.3% | -8.7% | |
| Q4 2016 | +5.8% | +6.5% | +6.0% | |
| Q3 2016 | -7.4% | — | — | |
| Q2 2016 | +7.1% | — | — | |
| Q1 2016 | +0.1% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -10.3% | — | — | |
| Q2 2015 | +8.6% | — | — | |
| Q1 2015 | +9.5% | — | — | |
| Q4 2014 | -4.1% | — | — | |
| Q3 2014 | -0.4% | — | — | |
| Q2 2014 | -5.7% | — | — | |
| Q1 2014 | -13.2% | — | — | |
| Q4 2013 | +0.5% | — | — | |
| Q3 2013 | +0.9% | — | — | |
| Q2 2013 | +7.0% | — | — | |
| Q1 2013 | -4.7% | — | — | |
| Q4 2012 | +12.8% | — | — | |
| Q3 2012 | +7.6% | — | — | |
| Q2 2012 | +9.7% | — | — | |
| Q1 2012 | -12.0% | — | — | |
| Q4 2009 | -5.4% | — | — | |
| Q4 2011 | -5.4% | — | — | |
| Q3 2011 | -0.9% | — | — | |
| Q3 2010 | -0.9% | — | — | |
| Q2 2010 | +2.2% | — | — | |
| Q2 2011 | +2.2% | — | — | |
| Q1 2010 | +3.6% | — | — | |
| Q1 2011 | +3.6% | — | — | |
| Q4 2010 | +3.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro